Loading...
XNYSMPLN
Market cap205mUSD
Jan 10, Last price  
12.73USD
1D
2.91%
1Q
20.44%
IPO
-96.76%
Name

Multiplan Corp

Chart & Performance

D1W1MN
XNYS:MPLN chart
P/E
P/S
0.21
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
38.85%
Rev. gr., 5y
-1.57%
Revenues
962m
-10.95%
1,067,266,0001,040,883,000982,901,000937,763,0001,117,602,0001,079,716,000961,524,000
Net income
-92m
L-83.99%
648,132,00036,223,0009,710,000-529,626,000102,080,000-572,912,000-91,697,000
CFO
172m
-53.88%
368,945,000292,303,000284,313,000377,374,000404,687,000372,364,000171,720,000
Earnings
Feb 26, 2025

Profile

MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services, which reduce medical costs through data-driven algorithms that detect claims over-charges and recommend or negotiate reimbursement; network-based services that reduce medical costs through contracted discounts with healthcare providers; and payment and revenue integrity services, which reduce medical costs by identifying and removing improper and unnecessary charges paid during the claim. It also provides health benefit plans, which features reference-based pricing and tools to engage health plan members and providers to make the use of benefits before and after care delivery. The company serves national insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, third party administrators, bill review companies, Taft-Hartley plans, and other entities that pay medical bills in the commercial healthcare, government, workers' compensation, and auto medical markets. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.
IPO date
Feb 10, 2020
Employees
2,500
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑12
Income
Revenues
961,524
-10.95%
1,079,716
-3.39%
Cost of revenue
791,478
370,935
Unusual Expense (Income)
NOPBT
170,046
708,781
NOPBT Margin
17.69%
65.65%
Operating Taxes
(15,363)
12,169
Tax Rate
1.72%
NOPAT
185,409
696,612
Net income
(91,697)
-83.99%
(572,912)
-661.24%
Dividends
Dividend yield
Proceeds from repurchase of equity
(15,218)
(99,999)
BB yield
0.04%
0.34%
Debt
Debt current
22,834
19,613
Long-term debt
4,571,758
4,790,007
Deferred revenue
Other long-term liabilities
17,275
2,470
Net debt
4,508,045
4,475,574
Cash flow
Cash from operating activities
171,720
372,364
CAPEX
(108,852)
(89,735)
Cash from investing activities
(249,792)
(104,446)
Cash from financing activities
(180,993)
(115,738)
FCF
155,372
695,036
Balance
Cash
71,547
334,046
Long term investments
15,000
Excess cash
38,471
280,060
Stockholders' equity
(511,018)
(347,733)
Invested Capital
6,810,093
6,889,185
ROIC
2.71%
9.79%
ROCE
2.49%
9.87%
EV
Common stock shares outstanding
645,135
638,926
Price
57.60
25.22%
46.00
-74.04%
Market cap
37,159,756
26.43%
29,390,582
-74.54%
EV
41,667,801
33,866,156
EBITDA
595,832
1,124,440
EV/EBITDA
69.93
30.12
Interest
333,208
303,401
Interest/NOPBT
195.95%
42.81%